VRCA - Verrica Pharmaceuticals Inc

Healthcare - Sector

VRCA is currently covered by 6 analysts with average potential upside of $6.94 (92.67%) backed by 6 price targets and 26 ratings. Analyst's average stock valuation to be materialised ratio is 15.67% with an average time for price targets to be met of 82.2 days.

Most recent stock forecast was given by OREN LIVNAT from HCWAINWRIGHT on 31-May-2022.

Highest price target for VRCA is 17, Lowest price target is 2, average price target is 9.5.

Best performing analysts who are covering VRCA - Verrica Pharmaceuticals Inc:

Serge Belanger Daniel Busby Timothy Chiang Oren Livnat Gregory Renza

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

12

$9.41 (363.32%)

5 months 27 days ago

0/4 (0%)

$8.54 (183.66%)

Hold

4

$1.41 (54.44%)

16

6 months 2 days ago

1/4 (25%)

$5.53 (76.38%)

79

Buy

6 months 2 days ago

1/5 (20%)

$8.64 (81.93%)

253

Buy

4

$1.41 (54.44%)

16

6 months 2 days ago

1/3 (33.33%)

$4.75 (68.82%)

79

Buy

18

$15.41 (594.98%)

24

1 years 2 months 6 days ago

0/4 (0%)

$7.24 (52.55%)

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login